Heterologous Effects of BCG in Healthy UK Adults

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Tuberculosis
Interventions
DRUG

BCG SSI

Intradermal injection

OTHER

No vaccination

DRUG

BCG Sii

intradermal injection

Trial Locations (3)

OX3 7LE

Centre for Clinical Vaccinology and Tropical Medicine , University of Oxford, Oxford

Oxford University Hospitals- John Warin Ward, University of Oxford, Oxford

B15 2TH

NIHR Wellcome Trust Clinical Research Facility, University of Birmingham, Birmingham

All Listed Sponsors
lead

University of Oxford

OTHER

NCT02380508 - Heterologous Effects of BCG in Healthy UK Adults | Biotech Hunter | Biotech Hunter